QualityStocksNewsBreaks – ORHub Inc. (ORHB) Settles Litigation with Former CFO

ORHub Inc. (OTC: ORHB), a growth stage data analytics company on a mission to optimize the business of surgery through lean process improvement, this morning announced that it has reached a resolution of its contract dispute with its former chief financial officer, Lanny Lang, and his firm, Lang Financial Services Inc. “It is unfortunate that Mr. Lang and the Company had to engage in litigation to resolve their dispute, but it should in no way reflect on the work Mr. Lang performed for the Company during its developmental phase between June 2016 and June 2018,” ORHub Chairman and CEO Colton Melby said in the news release. “With this matter now firmly behind us, the board and management team will focus on executing on the Company’s near- and long-term objectives to realize the potential of our innovative perioperative dashboard product, Surgical Spotlight, and to drive value for our shareholders.”

To view the full press release, visit http://ibn.fm/hkP0E

About ORHub Inc.

ORHub is a growth stage data analytics company on a mission to optimize the business of surgery through lean process improvement. As a Microsoft Silver Partner, ORHub leverages the Azure cloud to help customers unlock the power in their data captured in the OR. Surgical Spotlight® helps providers harness that data, identify millions of dollars in opportunities, and get leaders back to their primary focus: improving care, increasing patient access and reducing costs. A first-of-kind team building tool brings all stakeholders together with regular and accessible information. ORHub specializes in business intelligence for the operating room, built by professionals from the operating room. For more information, visit the company’s website at www.ORHub.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Provides Update on Lead Drug Candidate for Treatment of Non-Small Cell Lung Cancer

Clinical-stage gene therapy company Genprex Inc. (NASDAQ: GNPX) this morning provided an update on the development of its lead drug candidate, Oncoprex(TM) immunogene therapy, in combination with immunotherapy for the treatment of non-small cell lung cancer (“NSCLC”). Based on data from the ongoing study through GNPX’s July 2018 sponsored research agreement with The University of Texas MD Anderson Cancer Center, as well as prior clinical and pre-clinical studies, Genprex is working with its scientific advisory board and outside consultants to design a clinical trial for Oncoprex. According to the update, the new study will focus on Oncoprex in combination with a checkpoint inhibitor for the treatment of NSCLC, with a goal of enrolling patients in the first quarter of 2020.  “Recent studies have shown that less than half of cancer patients qualify for approved immunotherapies based on the patient’s PD-1 or PD-L1 protein expression level,” Genprex President and COO Julien Pham said in the news release. “Current immunotherapy treatment is only benefitting a small number of cancer patients. We are working to fill this gap by combining our lead drug candidate with approved immunotherapies to give patients more treatment options. The preclinical studies have shown encouraging data that this combination could be a viable treatment option for late-stage non-small cell lung cancer.”

To view the full press release, visit http://ibn.fm/EvAW3

About Genprex Inc.

Genprex, Inc. is a clinical stage gene therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. For more information, visit the company’s website at www.Genprex.com

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Nightfood Holdings Inc. (NGTF) Announces Winner Selection in ‘Year’s Supply Giveaway’ Promotion

Nightfood Holdings Inc. (OTCQB: NGTF), the nationally expanding company solving America’s $50 billion nighttime snacking problem, today announced selection of a winner in the company’s 96-pint giveaway, which ended on June 30, 2019. The winner lives in the Baltimore, Maryland, area and has been notified via email that he will receive 96 pints of Nightfood’s award-winning ice cream, in addition to a brand-new chest freezer in which to store his 12-month supply. “This campaign has been a huge success for us, introducing over half a million people to the Nightfood brand.  It’s allowed us to build direct relationships with a significant percentage of them while driving trial at retail,” Nightfood CEO Sean Folkson commented in the news release.  “With major geographic expansion already in place for the coming weeks and months, we’ve enthusiastically decided to duplicate the campaign for the 2nd half of the year.”

To view the full press release, visit http://ibn.fm/32SRb

About Nightfood Holdings

Nightfood Holdings Inc. owns Nightfood Inc. and MJ Munchies Inc. On February 8, 2019, it was announced that Nightfood ice cream won the ‘2019 Product of the Year’ award in the ice cream category in a Kantar survey of over 40,000 consumers. With the overwhelming majority of at-home ice cream consumption occurring in the hours before bed, Nightfood’s sleep-friendly nighttime ice cream, formulated by sleep and nutrition experts, delivers benefits found in no other product on the market. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for the coming years. For more information, visit the company’s website at www.Nightfood.com

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Enters Exclusive Agreement to Acquire Lifestyle Delivery Systems

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) on Saturday announced its entry into an exclusive agreement for the acquisition of Lifestyle Delivery Systems Inc. (CSE: LDS) (FSE: LD6) (WKN: A14XHT) (OTCQX: LDSYF) (“LDS”). According to the update, the companies will negotiate a proposed business combination that’s expected to involve TransCanna’s acquisition of all outstanding common shares of LDS at a price equal to the greater of $51,660,140 payable in common shares of TransCanna and the amount resulting from a fixed exchange ratio of one TransCanna common share for every 10 LDS common shares. “This has the potential to be a transformative acquisition by TransCanna. The combined company will expedite our processes and corporate goals by at least 24 months,” TransCanna CEO Jim Pakulis said in the news release. “TransCanna will be revenue generating, with the ability to immediately scale throughout California.”

To view the full press release, visit http://ibn.fm/5kZTh

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace. For more information, visit the company’s website at www.TransCanna.com

NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://ibn.fm/TCAN

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php